TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling.
Zheng H, Yang Y, Han J, Jiang WH, Chen C, Wang MC, Gao R, Li S, Tian T, Wang J, Ma LJ, Ren H, Zhou WP.
Zheng H, et al. Among authors: yang y.
Sci Rep. 2016 Nov 30;6:37070. doi: 10.1038/srep37070.
Sci Rep. 2016.
PMID: 27901021
Free PMC article.